Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease
Mutations in PINK1 cause early-onset Parkinson’s disease (PD). Studies in Drosophila melanogaster have highlighted mitochondrial dysfunction on loss of Pink1 as a central mechanism of PD pathogenesis. Here we show that global analysis of transcriptional changes in Drosophila pink1 mutants reveals an...
Saved in:
Published in: | Nature cell biology Vol. 16; no. 2; pp. 157 - 166 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
01-02-2014
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mutations in
PINK1
cause early-onset Parkinson’s disease (PD). Studies in
Drosophila melanogaster
have highlighted mitochondrial dysfunction on loss of Pink1 as a central mechanism of PD pathogenesis. Here we show that global analysis of transcriptional changes in
Drosophila pink1
mutants reveals an upregulation of genes involved in nucleotide metabolism, critical for neuronal mitochondrial DNA synthesis. These key transcriptional changes were also detected in brains of PD patients harbouring
PINK1
mutations. We demonstrate that genetic enhancement of the nucleotide salvage pathway in neurons of
pink1
mutant flies rescues mitochondrial impairment. In addition, pharmacological approaches enhancing nucleotide pools reduce mitochondrial dysfunction caused by Pink1 deficiency. We conclude that loss of Pink1 evokes the activation of a previously unidentified metabolic reprogramming pathway to increase nucleotide pools and promote mitochondrial biogenesis. We propose that targeting strategies enhancing nucleotide synthesis pathways may reverse mitochondrial dysfunction and rescue neurodegeneration in PD and, potentially, other diseases linked to mitochondrial impairment.
Mutations in
PINK1
cause early-onset Parkinson’s disease. Martins and colleagues find that the expression levels of genes involved in nucleotide metabolism are upregulated in a
Drosophila pink1
mutant, and that this affects neuronal mitochondrial DNA synthesis. They find that enhancing nucleotide synthesis through genetics or pharmacological approaches rescues mitochondrial defects associated with
PINK1
mutations. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS: A.Y.A., G.R.M., L.M.M., R.T. and S.H.Y.L. conceived and designed the experiments. A.Y.A., D.D., I.P.d.C., L.M.M., P.R.A., R.T., S.G., S.L. and S.H.Y.L. performed the experiments and analysed the data. R.T. did most of the experimental work and analysis. E.D. contributed materials. A.E.W., H.P-F. and P.N. provided experimental and conceptual advice. G.R.M., L.M.M., R.T., S.G. and S.H.Y.L wrote the paper. S.H.Y.L. and L.M.M. contributed equally as joint last authors. |
ISSN: | 1465-7392 1476-4679 |
DOI: | 10.1038/ncb2901 |